Empyrean Capital Partners LP acquired a new stake in shares of Teleflex Incorporated (NYSE:TFX – Free Report) in the 4th quarter, HoldingsChannel.com reports. The firm acquired 118,000 shares of the medical technology company’s stock, valued at approximately $14,401,000.
Several other institutional investors and hedge funds have also bought and sold shares of TFX. Empowered Funds LLC lifted its stake in Teleflex by 15.8% during the 1st quarter. Empowered Funds LLC now owns 1,684 shares of the medical technology company’s stock valued at $233,000 after acquiring an additional 230 shares during the period. Jane Street Group LLC lifted its stake in Teleflex by 42.6% during the 1st quarter. Jane Street Group LLC now owns 6,343 shares of the medical technology company’s stock valued at $877,000 after acquiring an additional 1,895 shares during the period. American Century Companies Inc. lifted its stake in Teleflex by 32.7% during the 2nd quarter. American Century Companies Inc. now owns 13,640 shares of the medical technology company’s stock valued at $1,614,000 after acquiring an additional 3,360 shares during the period. Invesco Ltd. lifted its stake in Teleflex by 1.2% during the 2nd quarter. Invesco Ltd. now owns 135,516 shares of the medical technology company’s stock valued at $16,040,000 after acquiring an additional 1,659 shares during the period. Finally, EverSource Wealth Advisors LLC lifted its stake in Teleflex by 108.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,003 shares of the medical technology company’s stock valued at $119,000 after acquiring an additional 521 shares during the period. 95.62% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several brokerages have commented on TFX. Wall Street Zen cut shares of Teleflex from a “hold” rating to a “sell” rating in a research note on Saturday, May 9th. Mizuho set a $140.00 target price on shares of Teleflex in a report on Friday, May 8th. Truist Financial reaffirmed a “hold” rating and set a $143.00 target price (up from $135.00) on shares of Teleflex in a report on Monday, May 11th. Wells Fargo & Company lifted their target price on shares of Teleflex from $130.00 to $138.00 and gave the company an “equal weight” rating in a report on Friday, May 8th. Finally, Zacks Research raised shares of Teleflex from a “strong sell” rating to a “hold” rating in a report on Tuesday, April 28th. Four analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Teleflex currently has an average rating of “Hold” and a consensus price target of $146.00.
Teleflex Price Performance
NYSE:TFX opened at $125.08 on Thursday. The company has a debt-to-equity ratio of 0.82, a current ratio of 2.55 and a quick ratio of 2.03. The firm has a market cap of $5.54 billion, a price-to-earnings ratio of -5.49, a price-to-earnings-growth ratio of 0.95 and a beta of 0.82. The company has a 50 day moving average price of $129.31 and a 200-day moving average price of $119.24. Teleflex Incorporated has a 1-year low of $100.18 and a 1-year high of $139.67.
Teleflex (NYSE:TFX – Get Free Report) last posted its earnings results on Thursday, May 7th. The medical technology company reported $1.39 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.18. The firm had revenue of $548.30 million during the quarter, compared to analyst estimates of $536.91 million. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The business’s quarterly revenue was up 32.3% on a year-over-year basis. During the same period in the previous year, the firm earned $1.44 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Equities research analysts forecast that Teleflex Incorporated will post 6.7 EPS for the current year.
Teleflex Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Monday, May 25th will be issued a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Friday, May 22nd. Teleflex’s payout ratio is presently -5.96%.
Teleflex Profile
Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.
The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.
Read More
- Five stocks we like better than Teleflex
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Free Report).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.
